Emotions Analysis in Patients With Chronic Phase of Stroke Basal Ganglia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

149 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2018-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Compare the emotional experience of patients with focal lesions of the basal ganglia by ischemic or hemorrhagic damage and healthy participants. These anomalies will be highlighted by neuropsychological and electrophysiological assessments.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis

NCT01530438

Amyotrophic Lateral Sclerosis

UNKNOWN NA

Clinical, Neurophysiological and Radiological Evaluation of Patients With Basal Ganglia Lesions

NCT00169325

Basal Ganglia Lesions

COMPLETED

Detection of Arousal With Facial Micro-expression in Severe Brain-damaged Patient

NCT03023657

Consciousness Disorder

TERMINATED NA

Cognitive Function Assessment in Patients With Focal Brain Injury

NCT04182087

Focal Brain Injury Cognition

RECRUITING

Subjective Perception of Motor Control During Psychogenic Disorders

NCT02843932

Somatoform Disorders

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Basal Ganglia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Emotional induction in stroke population

Six films are presented, each after a relaxation period after which the basal score is measured.

Group Type OTHER

Emotional induction

Intervention Type OTHER

Score (from 1 to 10) rated the felt for each target emotions for the following 6 dimensions: joy, sadness, fear, disgust, anger, no emotion, after the presentation of short sequences of standardized films.

Emotional induction in healthy volunteers

Six films are presented, each after a relaxation period after which the basal score is measured.

Group Type PLACEBO_COMPARATOR

Emotional induction

Intervention Type OTHER

Score (from 1 to 10) rated the felt for each target emotions for the following 6 dimensions: joy, sadness, fear, disgust, anger, no emotion, after the presentation of short sequences of standardized films.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Emotional induction

Score (from 1 to 10) rated the felt for each target emotions for the following 6 dimensions: joy, sadness, fear, disgust, anger, no emotion, after the presentation of short sequences of standardized films.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* For cases :

* right-handed patient
* ischemic or hemorrhagic stroke older than 3 months with single lesion preferably less than 20 mm in diameter affecting the basal ganglia and sparing cortex
* Rankin score estimated prior stroke must be equal to 0 and after stroke \<3 (at inclusion).
* For participants control : right-handed patient

Exclusion Criteria

* For cases : severe aphasia - Prosopagnosia apperceptive - cerebral neurological pathology associated history, especially dementia - History of depression and psychiatric disorders treated - another stroke vascular territory than that for which the patient is included - diffuse lesions of the white matter Fazekas a score of\> 2 (periventricular or subcortical) - Contraindications to MRI
* For participants control : No history neurosurgical - No history of head trauma with loss of consciousness - not known neurological disease - not known psychiatric illness - No psychotropic treatment

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes